FGEN Stock Analysis: Buy, Sell, or Hold?
FGEN - FibroGen, Inc
$9.71
0.69 (7.65%)
▲
HOLD
MODERATE Confidence
Last Updated: January 7, 2026
Get Alerted When FGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: FGEN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: FGEN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: FGEN is currently trading at $9.71, which is considered extended relative to its 30-day fair value range of $8.57 to $9.23.
Technical Outlook: Technically, FGEN is in a strong downtrend. The price is approaching resistance at $9.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.6% recently.
Market Sentiment: FGEN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $43.00 (+342.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, FGEN is in a strong downtrend. The price is approaching resistance at $9.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.6% recently.
Market Sentiment: FGEN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $43.00 (+342.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$8.57 -
$9.23
Company Quality Score
59/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
57.9%
Protect Your Profits
Holding FGEN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.2% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+7.6%)
- BULLISH: Trading 342.8% below Wall St target ($43.00)
Fair Price Analysis
30-Day Fair Range
$8.57 -
$9.23
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$8.36
Resistance Level
$9.75
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.81
Wall Street Target
$43.00
(+342.8%)
Revenue Growth (YoY)
774.8%
Earnings Growth (YoY)
53.6%
Profit Margin
2598.9%
Last updated: January 31, 2026 2:47 PM ET
Data refreshes hourly during market hours. Next update: 3:47 PM
Data refreshes hourly during market hours. Next update: 3:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced FGEN Option Strategies
Professional options setups generated by AI based on today's FGEN price and gamma walls.
